TrialEBioMedicine2025

Short-duration preoperative endocrine therapy alters molecular profiles to predict favourable outcome in ER+/HER2+ early breast cancer: a POETIC translational study.

Milana Bergamino Sirvén et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.